Chondroitin Sulfate N-Acetylgalactosaminyltransferase 1 (CSGALNACT1) Peptide
CSGALNACT1
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN975360
150,78 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination:
France
Envoi sous 15 à 22 jours ouvrables
Aperçu rapide pour Chondroitin Sulfate N-Acetylgalactosaminyltransferase 1 (CSGALNACT1) Peptide (ABIN975360)
Antigène
CSGALNACT1
(Chondroitin Sulfate N-Acetylgalactosaminyltransferase 1 (CSGALNACT1))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-CSGALNACT1 antibody (Catalog #: ARP47434_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- CSGALNACT1 (Chondroitin Sulfate N-Acetylgalactosaminyltransferase 1 (CSGALNACT1))
-
Sujet
-
CSGALNACT1 is a transfers 1,4-N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the non-reducing end of glucuronic acid (GlcUA). It is required for addition of the first GalNAc to the core tetrasaccharide linker and for elongation of chondroitin chains.
Alias Symbols: FLJ11264, beta4GalNAcT, ChGn, CSGalNAcT-1
Protein Size: 532 -
Poids moléculaire
- 61 kDa
-
ID gène
- 55790
-
NCBI Accession
- NM_018371, NP_060841
-
UniProt
- Q8TDX6
Antigène
-
Vous êtes ici:
